1. Welcome Address
  2. Committees and Organisers
  3. Congress Registration
  4. Scientific Programme
  5. Call for Poster Abstracts
  6. Brief Biography of Plenary Speakers
    1. Hans-Jürgen Möller, Germany
    2. Nora Volkow, USA
    3. Pasko Rakic, USA
    4. Barbara Sahakian, United Kingdom
    5. Jeff Conn, USA
    6. Siegfried Kasper, Austria
    7. Bengt Winblad, Sweden
    8. Arvid Carlsson
  7. CINP Awards
  8. General Information
  9. Social Programme
  10. Stockholm - Travel and Tours
  11. Exhibitors & Sponsors
  12. Hotel Accommodation
  13. Smartphone App
Platinum Sponsor
Gold Sponsor
Silver Sponsor

Host Organisation

CINP Central Office

Glenfinnan Suite, Braeview House
9/11 Braeview Place, East Kilbridge
Glasgow G74 3XH, Scotland UK

Phone: + 44-(0)-1355 244 930
Fax:       + 44-(0)-1355 249 959
Email: cinp[at]northernnetworking.co.uk

www.cinp.org

Congress Office

Hamburg Office
Hanser & Co GmbH
Zum Ehrenhain 34, 22885 Barsbüttel, Germany

Phone: +49-40-670 88 20
Fax:       +49-40-670 32 83
Email: cinp2012[at]cpo-hanser.de

www.cinp2012.com

Bengt Winblad, Sweden

Wednesday, 6 June 2012, 14.00 – 14.45 h

Drugs for Alzheimer‘s Disease

Professor Bengt Winblad, MD, PhD has been involved in the field of dementia research for many years. After pre-clinical medical studies in Vienna, Austria, he became MD 1971 and took his PhD in 1975 at Umeå University, Sweden, where he became a Docent in 1977 and Professor of Geriatric Medicine and Chief Physician in 1982. Bengt Winblad has been a guest professor at the Department of Psychiatry in Frankfurt and appointed honorary professor at Beijing University, Wuhan University and Shanghai University in China. Since 1987, he is working in Stockholm, Sweden as Professor of Geriatric Medicine at the Karolinska Institutet and is Chief Physician at Karolinska University in Huddinge.

Professor Winblad is co-chairing the European Alzheimer Disease Consortium (EADC) and chairing the Medical Scientific Advisory Panel of the Alzheimer Disease International (ADI). He is the Head of the KI-Alzheimer Disease Research Center in Huddinge including KASPAC (KI Dainippon Sumitomo Alzheimer Center), as well as the Director of the Swedish Brain Power research network.

Bengt Winblad’s research interests focus on the epidemiology, genetics and treatment of Alzheimer’s disease. He has been presented with a number of awards for his contribution to this research area, which have included the Swedish Society of Medicine Alzheimer Award, the Royal Swedish Academy of Medical Sciences Award, the Alois Alzheimer Award, the Swedish Society of Medicine Award and the IPA Recognition Award for Service to the Field of Psychogeriatrics. He has taken the initiative regarding pharmaceutical treatment of patients with severe Alzheimer’s disease. Professor Winblad has been a tutor for more than 150 PhD dissertations and has published more than 1000 original publications in the field of gerontology/geriatrics/dementia research.

Bengt Winblad, together with Khalid Iqbal and Henry ­Wisniewski, is the founder of the ICAD conferences.

Bengt Winblad was in 2009 ranked the world’s most profilic researcher in the Alzheimer field (J Alzheimer’s Disease 2009).